Oral drug delivery for Macromolecules using softgel lipid delivery systems to be presented by Catalent expert
28 November 2012 | By Catalent Pharma Solutions
Jeffrey E. Browne at Catalent Pharma Solutions will be presenting...
List view / Grid view
28 November 2012 | By Catalent Pharma Solutions
Jeffrey E. Browne at Catalent Pharma Solutions will be presenting...
28 November 2012 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc..
28 November 2012 | By Abbott
Abbott board of directors approved the separation of its research-based pharmaceuticals business...
27 November 2012 | By kdm communications limited
Tecan has developed an AlphaScreen® module for its popular Infinite® F200 PRO multimode reader...
27 November 2012 | By kdm communications limited
LoGiCal® reference materials from LGC Standards have enabled Spark Holland to establish an online SPE-LC/MSMS method...
27 November 2012 | By Novo Nordisk
New data analyses...
27 November 2012 | By Abbott
Abbott announced that the European Commission has approved HUMIRA®...
27 November 2012 | By Gilead Sciences, Inc.
Gilead Sciences announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread®...
27 November 2012 | By Merck
Novel personalized treatment approach targets folate receptors on cancer cells...
27 November 2012 | By Gilead Sciences
Gilead Sciences announced topline results from the Phase 3 POSITRON study...
26 November 2012 | By GlaxoSmithKline
GSK and GSK Nigeria have reached agreement...
20 November 2012 | By Novartis
The US FDA approved the use of Flucelvax®...
20 November 2012 | By GlaxoSmithKline
GSK will be a headline partner at the Coronation Festival...
20 November 2012 | By Bristol-Myers Squibb Company
The EC has approved ELIQUIS®...
Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma’s Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.